Nadia Harbeck,MD PhD @Prof_Nadia_H Twitter profile

Last Seen Profiles

@PDXzane

@Hinon1009

@95Ticonderoga

@HelenMalo118021

@g35il2fLq9tk8E

@iPrabhatThakur

@SrebrenicaMC

@DavidHongMD

@csphoto_atl

@CapitanaGusilu

@sataaaluvvsss

@diq43

@sammithedoxie

@LilianCuj

@XenoZero88200

@Bettyshirley226

@5PRewt130EN3HHk

@maximinthemax

@bezfrazi

@StanfordMGym

@MordredParody

@DeMoNCa20843528

@1lkD2e4rsddh0tr

@GromovCS

@Imneko16

@vkokoszka

@mahisaysnothing

@walton_wonderer

@armiiorkow

@alex_sieg90

@AdamCzech13

@xiny340577

@LeannM60488

@erynnyen

@YoloDana__

@hzmkga

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Proud Mom moment yesterday with daniel giving his first ASCO presentation @dkatesharbeck @OncoAlert #ASCO24

2

4

59

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Excited to be joining the X community!

11

10

57

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Chairing an Oxford discussion on Ki67 at the Annual German Senology Conference. Amazing to see that about 70% of the breast centers use endocrine response assessment in clinical routine according to WSG ADAPT. #OncoAlert

1

8

25

Nadia Harbeck,MD PhD

@Prof_Nadia_H

3 months

Welcome to Munich #myESMOGI24 looking forward to an exciting. Scientific exchange #OncoAlert

0

3

21

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Great selection. Excited to see indications for ADCs expanding at #ASCO24

OncoAlert

@OncoAlert

4 months

Dear Colleagues, The @OncoAlert 🚨Network Presents OUR Picks of TOP 🔟Abstracts to be Presented at #ASCO24 This List Curated by: #OncoAlertAF Leads : @ElisaAgostinett 🇧🇪 @to_be_elizabeth 🇮🇹 @weoncologists 🇺🇸 With our distinguished OncoAlert Faculty: @ErikaHamilton9 🇺🇸 @DrSGraff

0

50

95

0

4

21

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Happy to be part of the @OncoAlert community and honored to be nominated for @myESMO president 2027-28. Please remember to cast your votes

OncoAlert

@OncoAlert

4 months

Dear Colleagues, VOTING has NOW started for @myESMO President 2027-28 and will Remain Open until June 10, 2024. The Candidates are🚨OncoAlert Faculty: ✅Prof. Nadia Harbeck @Prof_Nadia_H 🇩🇪 ➡️Director of @LMU_Muenchen #BreastCancer Center & ✅Prof. Giuseppe Curigliano @curijoey

0

15

35

0

5

21

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

WSG proudly presents the ADAPT HER2 IV trial. Already 36 patients enrolled in this neoadjuvant deescalation trial with TDXd in HER2+ EBC. @dkatesharbeck @OncoAlert

1

5

18

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

What a great collaborative effort. Proud to be a part of it @OncoAlert OncoAlert

Matteo Lambertini, MD PhD

@matteolambe

4 months

Looking forward to presenting today at #ASCO24 results of our BRCA BCY Collaboration providing evidence on clinical behavior of #BreastCancer in 4752 young #BRCA carriers according to specific BRCA gene and association of timing of genetic testing with prognosis @OncoAlert #bcsm

2

30

107

0

4

17

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Important data but we need to be careful as observational data on OS not breast cancer recurrences. Inherent bias cannot be excluded. @OncoAlert e

Hope Rugo

@hoperugo

4 months

Would caution major caution in interpreting this data. This is an extremely heterogenous disease. ER<5% and most <10% unlikely to benefit from ET. Argues for neoadj chemo in this hi risk setting. PCR had no benefit. Careful eval of heterogeneity - not a median @OncoAlert #ASCO24

3

19

77

1

6

14

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Excited about our upcoming ESMO real world case discussion this Tuesday, May 28 at 18:30 CEST with @Rodrosb , Alessandra Gennari, Andri Papakonstantino, and Seock-Ah Im. More info here: @OncoAlert

0

5

14

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Fantastic #ASCO24 great connecting again. Hope everyone got home safe. See you all at #ESMO in Barcelona #OncoAlert

1

3

13

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Congratulations well deserved! @OncoAlert

Ines Vaz Luis

@ines_vazluis

4 months

Such an honor to receive a mentorship award. So grateful for outstanding mentorship @nlinmd @AnnPartridgeMD @DrEricWiner @DrRFreedman , the best mentees @AliceFranzoi @dimeglio_anto @PLapidari @marti_pagliuca @camila_chiodi @ajrsferreira , @ConquerCancerFd and @GustaveRoussy

19

13

101

1

3

12

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Totally agree, further encouragement for neoadjuvant therapy in early TNBC as adjuvant IO by itself is not effective!

Evandro de Azambuja, MD, PhD

@E_de_Azambuja

4 months

Important Overall Survival results in KEYNOTE-522. Important advance for our patients with #early TNBC, but we are still waiting biomarker analyses for this trial... @FDAOncology @OncoAlert @Merck #bcsm #research

0

8

20

0

2

12

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Very good and balanced discussion by Dr. Krop today. Hopefully we will get the approval extension soon so that we can individualize treatment with TDXd in HER2-low MBC like he suggested in his algorithm @OncoAlert

Hope Rugo

@hoperugo

4 months

@OncoAlert

0

3

7

1

4

10

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

It’s a privilege to wrap up #ASCO24 for our patients @renatehaidinger #OncoAlert

Renate Haidinger

@renatehaidinger

4 months

Today I moderated the live round table from #ASCO24 for my organization, the German Breast Cancer Ass. Huge thanks to all specialist who wrapped up the ASCO meeting in a patient friendly language. ⁦ @Prof_Nadia_H ⁩ Prof.Janni, Prof. Untch, Prof. Ditsch, Prof.Müller

0

2

12

1

3

9

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Congratulations to @dkatesharbeck for receiving an @asco24 conquer cancer award for his abstract #OncoAlert

Nancy Lin, MD

@nlinmd

4 months

Terrific presentation from Daniel Kates-Harbeck showing the potential for multimodal AI models to predict prognosis in HR+ breast ca w/in WSG PlanB and ADAPT. ⁦Adds to prognostication beyond traditional clin-path factors ⁦ @arteraAI ⁩ ⁦⁦ @Prof_Nadia_H ⁩

0

4

11

0

4

7

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Encouraging efficacy!

Hope Rugo

@hoperugo

4 months

@FAndreMD presents DB07. The expected amazing and durable response to first line TDXd +/- Pertuzumab. Adding P almost tripled grade 3 diarrhea rates; no grade 5 ILD. Imp implications for DB09 and great to see this efficacy. #ASCO24 @OncoAlert

1

19

41

0

2

6

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Great discussion last night on personalized prevention and detection of breast cancer. You can still watch it on demand and collect points towards your #myESMO certificate of professional development. #OncoAlert

ESMO - Eur. Oncology

@myESMO

4 months

➡️ Enhance your ESMO membership! Register now to delve into #BreastCancer knowledge and engage with experts in real-time. Don't miss out on staying informed and connected. Register now: 🔗

0

8

13

1

3

6

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Please don’t forget to join us today Wednesday June 5 6:30 pm CEST for another #myESMO breast cancer deep dive webinar #oncoalert

0

3

5

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Congratulations @felixfengmd for this well deserved @ASTRO Award. Such a privilege to be working on amazing science together with Felix. #OncoAlert

Toni Choueiri, MD

@DrChoueiri

4 months

Congratulations to super star mentor @felixfengmd for winning a very well deserved 2024 Mentor of the Year Award from @ASTRO_org !! —I would say Mentor of the Century too !

0

19

98

0

3

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Couldn’t agree more. Fantastic work by #myriamChalabi and colleagues #Oncoalert

MarleenKokLab

@lab_kok

4 months

Super proud of my colleague and rockstar @MyriamChalabi with @HaanenJohn @NKI_nl . With short-term IO most of the MMRd colon cancer responded beautifully! #makingimpact

4

8

68

0

2

4

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Great news for patients #ASCO24 @OncoAlert

Myriam Chalabi

@MyriamChalabi

4 months

👏👏👏👏 #NADINA - Neoadj 2 cycles of ipi/nivo is better than adj 12x nivo! - pts with MPR did not receive adj IO: these pts did even better! - now we have to make this standard of care!!! @ProfGLongMIA @ProfCUBlankNKI @NKI_nl @ASCOPost

3

27

95

0

3

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Excited about this #ASCO24 session Saturday morning Lots of innovative ideas on AI in oncology intriguing results from WSG PlanB and ADAPT . #OncoAlert

0

3

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Great effort! @OncoAlert

Helena Linardou

@ElinardouHelena

4 months

Happening now: The Lancet Comission on Women, Power and Cancer. Join us - a stellar panel of inspiring women and great presentations! #ASCO24 @myESMO @NarjustFlorezMD @amanda_psyrri @OphiraG

0

2

18

0

3

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

@dkatesharbeck presented results from WSG PlanB and ADAPT showing that a multimodal AI model predicts outcome in HR+ HER2- EBC even within clinical subgroups #ASCO24 @OncoAlert

0

3

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Fantastic news for patients! @OncoAlert

Helena Linardou

@ElinardouHelena

4 months

That unique amazing feeling of the Plenary when practice-changing results are presented… Great day for thoracic oncology! LAURA and ADRIATIC - two immediately practice-changing studies in areas of unmet need! #ASCO24 @myESMO

0

3

19

0

2

Nadia Harbeck,MD PhD

@Prof_Nadia_H

4 months

Glad Kathrin @heinrich_ views us this way. The purpose of a role model should be to help others grow and advance themselves by positive support and encouragement #OncoAlert

Kathrin Heinrich

@heinrich_kat

4 months

#WomenInScience ! It is fantastic to see so many #rolemodels in one picture 😍 @OncoAlert 🚨 #ASCO24

0

3

11

0

1